Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natura-Alpha in Active Ulcerative Colitis
NCT01216280Phase 2Unknown
- Sponsor
- Natrogen Therapeutics International, Inc.
- Start
- Jul 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAK-114 in ulcerative colitis (UC), sponsored by Natrogen Therapeutics International, Inc.. Status: unknown.
02
Drugs
TAK-114
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01216280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216280.